title: Raising the bar for market authorisation of new drugs.
authors.affiliation: LSE Health, London School of Economics and Political Science, London, UK.
authors.forename: Huseyin
authors.initials: H
authors.lastname: Naci
authors.forename: Jonathan
authors.initials: J
authors.lastname: Cylus
authors.forename: Sotiris
authors.initials: S
authors.lastname: Vandoros
authors.forename: Azusa
authors.initials: A
authors.lastname: Sato
authors.forename: Kumar
authors.initials: K
authors.lastname: Perampaladas
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends; D005060:Europe; D019317:Evidence-Based Medicine; D007880:Legislation, Drug / Q000639:trends; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration